<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><copyright>(C) Copyright 2004-2026 Pillole.org - Tutti i diritti riservati</copyright><title>Le Ultime Pillole</title><description>Pillole di medicina telematica Informazione professionale medica </description><atom:link href="http://www.pillole.org/public/aspnuke/newsxml.asp?xmlid=3390" rel="self" type="application/rss+xml" /><link>http://www.pillole.org/public/aspnuke/newsxml.asp?xmlid=3390</link><pubDate>Fri, 10 Apr 2026 01:38:40 +0100</pubDate><docs>http://www.pillole.org/public/aspnuke/news.asp?id=3390</docs><generator>Pillole.org</generator><category>News</category><managingEditor>info@pillole.org (Luca Puccetti)</managingEditor> <webMaster>info@pillole.org (Luca Puccetti)</webMaster><language>it-it</language><image><title>Le Ultime Pillole</title><url>http://www.pillole.org/klip/logopillolesmall.gif</url><link>http://www.pillole.org/public/aspnuke/newsxml.asp?xmlid=3390</link><width>16</width><height>16</height><description>Pillole di medicina telematica</description></image><item><enclosure url="http://www.pillole.org/public/aspnuke/downloads/immagini/diabetico.jpg"  length="1" type="image/jpeg" /><pubDate><![CDATA[Sat, 26 May 2007 00:00:00 +0100]]></pubDate><title><![CDATA[Allarme (ingiustificato?) sul rischio di infarto miocardico con rosiglitazone]]></title><description><![CDATA[Una criticata e criticabile metanalisi del New England Journal of Medicine accende una polemica sulla sicurezza cardiovascolare del rosiglitazone.

]]></description><link><![CDATA[http://www.pillole.org/public/aspnuke/news.asp?id=3390]]></link><guid><![CDATA[http://www.pillole.org/public/aspnuke/news.asp?id=3390]]></guid></item></channel></rss>